Advanced search
Publication Cover
Journal of Chemotherapy Volume 30, 2018 - Issue 1
Submit an article Journal homepage
217
Views
0
CrossRef citations to date
0
Altmetric
Anticancer Original Research Paper

Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy

Ali Hakan KayaHematology Clinic and Bone Marrow Transplantation Unit, University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, TurkeyCorrespondence[email protected]
,
Emre TekgündüzHematology Clinic and Bone Marrow Transplantation Unit, University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey
,
Kadir IlkkiliçDepartment of Hematology, Faculty of Medicine, Pamukkale University, Denizli, Turkey
,
Mehmet Sinan DalDepartment of Hematology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey
,
Alparslan MerdinHematology Clinic and Bone Marrow Transplantation Unit, University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey
,
Abdullah KarakusDepartment of Hematology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey
,
Sibel Kabukcu HaciogluDepartment of Hematology, Faculty of Medicine, Pamukkale University, Denizli, Turkey
,
Filiz BekdemirHematology Clinic and Bone Marrow Transplantation Unit, University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey
,
Merih Kızıl ÇakarHematology Clinic and Bone Marrow Transplantation Unit, University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey
,
Mehmet Hilmi DoguDepartment of Hematology, Faculty of Medicine, Pamukkale University, Denizli, Turkey
,
Mehmet Orhan AyyildizDepartment of Hematology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey
,
Serdal KorkmazHematology Clinic and Bone Marrow Transplantation Unit, University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey
,
Fevzi AltuntaşHematology Clinic and Bone Marrow Transplantation Unit, University of Health Sciences Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey
& On the behalf of The Turkish Hematology Research and Edication Group (ThREG) show all
Pages 44-48 | Published online: 03 Nov 2017

References

  • Walter RB, Othus M, Burnett AK, Lowenberg B, Kantarjian HM, Ossenkoppele GJ, et al. Resistance prediction in aml: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOC and MD Anderson Cancer Center. Leukemia. 2014;29:312–20.
  • Available from: https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx
  • Acute Myeloid Leukemia. NCCN clinical practice guidelines in oncology (NCCN Guidelines). Version 1; 2016. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx
  • Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–74.10.1182/blood-2009-07-235358
  • Ravandi F. Relapsed acute myeloid leukemia: why is there no standard of care? Best Pract Res Clin Haematol. 2013;26:253–9.10.1016/j.beha.2013.10.005
  • Cornelissen JJ, van Putten WLJ, Verdonck LF, Theobald M, Jacky E, Daenen SM, et al. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood. 2007;109(9):3658–66.10.1182/blood-2006-06-025627
  • Yanada M, Matsuo K, Emi N, Naoe T. Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission. Cancer. 2005;103(8):1652–8.10.1002/(ISSN)1097-0142
  • Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission. JAMA. 2009;301(22):2349–61.10.1001/jama.2009.813
  • Tran H, Yang D. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults. Ann Pharmacother. 2012;46:89–96.10.1345/aph.1Q295
  • Kantarjian HM, Jeha S, Gandhi V, Wess M, Faderl S. Clofarabine: past, present, and future. Leuk Lymphoma. 2007;48:1922–30.10.1080/10428190701545644
  • Becker PS, Kantarjian HM, Appelbaum FR, Petersdorf SH, Storer B, Pierce S, et al. Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia. Br J Haematol. 2011;155(2):182–9.10.1111/j.1365-2141.2011.08831.x
  • Faderl S, Wetzler M, Rizzieri D, Schiller G, Jagasia M, Stuart R, et al. Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I trial. J Clin Oncol. 2012;30:2492–2499.10.1200/JCO.2011.37.9743
  • Cheson BD, Bennett JM, Kopecky KJ, Büchner T, Willman CL, Estey EH, et al. Revised recommendations of the ınternational working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003;21(24):4642–9.10.1200/JCO.2003.04.036
  • US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published May 28, 2009 (v.403: June 14, 2010).
  • Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-ıntensity conditioning regimen workshop: defining the dose spectrum. Report of a Workshop convened by the center for ınternational blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15:367–9.10.1016/j.bbmt.2008.12.497
  • Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.10.3322/caac.21208
  • Scappini B, Gianfaldoni G, Caracciolo F, Mannelli F, Biagiotti C, Romani C, et al. Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. Am J Hematol. 2012;87:1047–51.10.1002/ajh.v87.12
  • Faderl S, Gandhi V, O’Brien S, Bonate P, Cortes J, Estey E, et al. Results of a phase 1–2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias. Blood. 2005;105:940–947.
  • Shah A, Andersson TM, Rachet B, Björkholm M, Lambert PC. Survival and cure of acute myeloid leukaemia in England, 1971–2006: a population-based study. Br J Haematol. 2013;162:509–16.10.1111/bjh.2013.162.issue-4
  • Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary ınduction failure. J Clin Oncol. 2010;28(23):3730–8.10.1200/JCO.2010.28.8852
  • Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weissinger E, Bunjes D, et al. Long- term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy andreduced-intensity conditioning for allogeneic stem cell transplantation. Blood. 2006;108:1092–9.10.1182/blood-2005-10-4165

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.